Alterations in the oxygen deficit-oxygen debt relationships with beta-adrenergic receptor blockade in man

R L Hughson, R L Hughson

Abstract

The effects of beta-adrenergic receptor blockade (100 mg oral metoprolol) or matched placebo on gas exchange kinetics were studied in six males. Ventilation and gas exchange were monitored in four transitions for each treatment from loadless pedalling (0 W) to a selected work rate (100 W) and back to 0 W. Breath-by-breath data were averaged for analysis. Oxygen uptake (VO2) kinetics were significantly slowed at the onset of exercise and recovery by beta-blockade. This resulted in larger oxygen deficit and oxygen debt (671 +/- 115, 586 +/- 87 ml O2, respectively) for beta-blockade than for placebo (497 +/- 87, 474 +/- 104 ml O2). In addition, oxygen deficit was significantly larger than oxygen debt during beta-blockade tests. These results can be explained by greater utilization of oxygen and creatine phosphate stores as well as anaerobic glycolysis at the onset of 100 W exercise with beta-blockade. Carbon dioxide output (VCO2) kinetics were significantly slowed by beta-blockade only at the onset of exercise. Expired ventilation (VE) kinetics were not affected by beta-blockade. At 0 W, VE was significantly reduced by beta-blockade. Heart rate was lower at all times with beta-blockade. Kinetics of heart rate were not affected. These data for VO2 kinetics at the start and end of exercise indicate that even in moderate-intensity exercise, lactic acid production can contribute significantly to energy supply. The use of the term ' alactic ' to describe the deficit and debt associated with this exercise is not appropriate.

References

    1. J Appl Physiol Respir Environ Exerc Physiol. 1983 May;54(5):1306-13
    1. J Physiol. 1937 Jun 3;89(4):462-6
    1. Arbeitsphysiologie. 1950;14(3):251-4
    1. J Appl Physiol. 1971 May;30(5):632-5
    1. J Appl Physiol Respir Environ Exerc Physiol. 1982 Apr;52(4):921-9
    1. J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):708-15
    1. J Appl Physiol. 1974 Apr;36(4):399-402
    1. Can J Physiol Pharmacol. 1981 Jun;59(6):567-73
    1. J Appl Physiol Respir Environ Exerc Physiol. 1981 Dec;51(6):1662-75
    1. Clin Sci (Lond). 1981 Sep;61(3):299-305
    1. Respir Physiol. 1977 Jun;30(1-2):81-97
    1. Am J Physiol. 1971 Apr;220(4):1053-9
    1. J Appl Physiol Respir Environ Exerc Physiol. 1982 May;52(5):1349-52
    1. Scand J Clin Lab Invest. 1978 May;38(3):229-32
    1. Br J Clin Pharmacol. 1980 Dec;10(6):624-5
    1. J Appl Physiol. 1971 Feb;30(2):261-3
    1. J Appl Physiol Respir Environ Exerc Physiol. 1977 Feb;42(2):133-8
    1. J Appl Physiol Respir Environ Exerc Physiol. 1982 Sep;53(3):549-54
    1. J Appl Physiol Respir Environ Exerc Physiol. 1981 Oct;51(4):788-93
    1. J Appl Physiol. 1969 Dec;27(6):813-6
    1. J Appl Physiol. 1951 Jan;3(7):427-38
    1. J Appl Physiol. 1970 May;28(5):657-62
    1. J Appl Physiol. 1973 Aug;35(2):236-43
    1. Acta Physiol Scand Suppl. 1974;415:1-68
    1. Int J Sports Med. 1983 Feb;4(1):31-9
    1. J Appl Physiol Respir Environ Exerc Physiol. 1982 Jun;52(6):1506-13
    1. J Appl Physiol. 1970 Apr;28(4):452-6
    1. Pflugers Arch. 1976 Dec 28;367(2):137-42
    1. Acta Physiol Scand. 1982 Nov;116(3):215-22
    1. Br J Clin Pharmacol. 1980 May;9(5):493-8
    1. Br J Clin Pharmacol. 1979 Aug;8(2):143-8
    1. Br Med J. 1976 Nov 20;2(6046):1229-31
    1. J Appl Physiol. 1972 Sep;33(3):351-6
    1. Circulation. 1982 Jun;65(6):1171-7
    1. J Appl Physiol. 1956 May;8(6):608-14
    1. J Clin Invest. 1965 Nov;44(11):1745-53
    1. Eur J Clin Pharmacol. 1978 Mar 17;13(1):5-8
    1. J Appl Physiol. 1971 Jun;30(6):838-43
    1. Med Sci Sports. 1970 Winter;2(4):177-81
    1. Can J Physiol Pharmacol. 1983 Sep;61(9):1010-6

Source: PubMed

3
Abonnieren